Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bone marrow hematopoietic stem cell niche is a highly specialized microenvironment that governs the maintenance, self-renewal, and differentiation of hematopoietic stem cells (HSCs). It is anatomically divided into the endosteal (or osteoblastic) niche, which is located near the bone surface and promotes HSC quiescence, and the perivascular niche, which is situated near blood vessels and facilitates HSC proliferation and mobilization into the circulation. This complex system involves interactions between HSCs and various cellular components, including osteoblasts, mesenchymal stem cells, endothelial cells, and immune cells, mediated by signaling axes such as CXCL12/CXCR4 and SCF/c-Kit. In pathological states like leukemia and metastatic cancer, the niche can be hijacked to protect malignant cells from chemotherapy, leading to drug resistance and disease recurrence. Consequently, the niche is a critical therapeutic target; drugs like Plerixafor and G-CSF are routinely used to mobilize HSCs for transplantation, while newer strategies aim to disrupt the protective environment to sensitize cancer cells to treatment.
Mobilization of hematopoietic stem cells via CXCR4 antagonism, disruption of E-selectin-mediated adhesion, and modulation of the bone marrow microenvironment through cytokine signaling and osteoblast inhibition.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone marrow hematopoietic stem cell niche (HSC niche).